Gyala Therapeutics

Private

BarcelonaHealthcare & Life Scienceshttps://gyalatx.com/

Last Round

Grant

Feb 11, 2026

Total Funding Raised

$6.12M

Company Overview

Gyala Therapeutics is a biotechnology company developing next-generation immunotherapies for hematological cancers with high unmet need.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2G

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

CAR-T cell therapyCAR-T therapycell therapyfirst-in-class therapyacute myeloid leukemiaAMLT-cell acute lymphoblastic leukemiaT-ALLCD84 targetautologous cell therapycancer immunotherapyleukemia treatmentblood cancer treatmenthematologic cancergene therapyoncologyclinical-stage biotechnology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Gyala Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Gyala Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Gyala Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Feb 11, 2026
VC Round	Oct 14, 2024
Seed	May 26, 2020

View all Funding Rounds

Key People

Founding team and executive leadership

Claudio Santos

Chief Executive Officer

Executive Team

Gyala Therapeutics Investors

Notable investors and investment history

Gyala Therapeutics investors
Investor	Rounds
Nara Capital	VC Round
Center for Technological Development and Innovation	VC Round
Invivo Partners	VC Round

View all Investors

Gyala Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Gyala Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Gyala Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersBarcelona

Employee Range8

Year Founded2020

Last FundingFeb 11, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.